Thus, TP53-depleted HNSCC cells demonstrate remarkable accumulation of SSB and DSB DNA damage markers and PARP1 cleavage in response to adavosertib, compared with TP53 WT (wild type) cells. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.